Skip to content

Diurnal Evaluation of OSA Upper Airway Collapsibility and Muscle Responsiveness

Diurnal Evaluation of Obstructive Sleep Apnea (OSA) Upper Airway Collapsibility and Muscle Responsiveness

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06334601
Acronym
Muscle-OSA
Enrollment
66
Registered
2024-03-28
Start date
2023-01-15
Completion date
2025-12-31
Last updated
2025-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

Collapsibility of upper airways, Muscle responsiveness

Brief summary

In the framework of pathophysiological trait in obstructive sleep apnea (OSA) patients, a simplified method is proposed to measure upper airway (UA) collapsibility and muscle responsiveness during wakefulness.

Interventions

DIAGNOSTIC_TESTTests of upper airway collapsibility and muscle responsiveness.

Upper airway collapsibility, upper airway muscle responsiveness and loop gain will be assessed during single study visit. Polysomnography

Sponsors

Istituto Auxologico Italiano
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Obstructive Sleep Apnea (OSA) * At home-polygraphy with at least one EEG channel (PSG) reporting moderate-to severe obstructive sleep apnea (apnea-hypopnea index \>14).

Exclusion criteria

* OSA treatment ongoing during two weeks before PSG * Unstable cardio-respiratory disease in the 3 months before enrollment * Subjects in O2 treatment

Design outcomes

Primary

MeasureTime frameDescription
Upper airway collapsibilityDuring the diagnostic testEvaluation during wakefulness
Upper airway muscle responsivenessDuring the diagnostic testEvaluation during wakefulness

Countries

Italy

Contacts

Primary ContactElisa Perger, MD
e.perger@auxologico.it+390261911

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026